Article and Video CATEGORIES
Dr. Gupta is currently an Oncology Fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
For information on Dr. Gupta see the following links -
GRACE is very happy to bring to you more videos from our program, Supportive Care in Cancer Treatment.
In this video our host, Dr. Arjun Gupta speaks with Shaalan Beg, MD, with UT Southwestern Medical Center in Dallas, TX . Dr. Beg and Dr. Gupta discuss Malignant Ascites, or fluid in the belly, in patients with cancer.
Ascites is the fluid that can accumulate within the peritoneal cavity. Cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma are generally the most common cancers that may develop ascites.
For further information, Drs. Gupta and Beg have recently also published a patient page in JAMA Oncology - you can view the patient page here:
https://jamanetwork.com/
A huge thankyou to our sponsors who have made this series possible!
To join the conversation, visit https://cancergrace.org/forum.
To find additional CancerGRACE resources, visit https://cancergrace.org.
To donate to CancerGRACE, visit https://cancergrace.org/donate.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…